PYC THERAPEUTICS LIMITED - Announcements

6.43%

$1.33

Market Cap $772.8M

Healthcare Biotechnology

PYC Therapeutics Limited is an Australia-based clinical-stage biotechnology company... PYC Therapeutics Limited is an Australia-based clinical-stage biotechnology company creating a new generation of ribonucleic acid (RNA) therapies to change the lives of patients with genetic diseases. The Company utilizes its proprietary drug delivery platform to enhance the potency of precision medicines within the rapidly growing and commercially proven RNA therapeutic class. Its drug development programs target monogenic diseases - the indications with the highest likelihood of success in clinical development. Its first-in-class drug programs include Retinitis Pigmentosa type 11, (VP-001), Polycystic Kidney Disease, (PYC-003), Autosomal Dominant Optic Atrophy (ADOA) (PYC-001) and Phelan-McDermid Syndrome (PMS) (PYC-002). The Company's VP-001 program is a lead asset for a blinding eye disease of childhood progressed through multiple patient cohorts in the ongoing single ascending dose clinical trial. ADOA is a progressive and blinding eye disease.More

ASX:AFP

Could this ASX stock become the next Pfizer? A look at AFT Pharmaceuticals (ASX:AFP). With biotech stocks broadly having a strong run in 2025, and with more of the year ahead, investors are still looking for stocks in the sector with room to run. Latest:...

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

PYC	Response to ASX Query	PRICE SENSITIVE	24/07/17	161.27KB	Share
PYC	Operational Update June quarter	PRICE SENSITIVE	11/07/17	208.37KB	Share
PYC	CEO and CSO Appointments	PRICE SENSITIVE	19/06/17	90.08KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	26/04/17	50.08KB	Share
PYC	Operational Update March Quarter	PRICE SENSITIVE	04/04/17	237.51KB	Share
PYC	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/17	312.79KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/17	157.53KB	Share
PYC	Response to ASX Price Query	PRICE SENSITIVE	30/01/17	231.58KB	Share
PYC	Genentech extends research collaboration period	PRICE SENSITIVE	19/12/16	139.08KB	Share
PYC	NHMRC Grant Awarded to Collaborators	PRICE SENSITIVE	05/12/16	137.54KB	Share
PYC	AGM Presentation to Shareholders	PRICE SENSITIVE	25/11/16	3.38MB	Share
PYC	Appendix 4C - quarterly-PYC.AX	PRICE SENSITIVE	31/10/16	157.1KB	Share
PYC	Shareholder Update-PYC.AX	PRICE SENSITIVE	30/09/16	697.77KB	Share
PYC	Appendix 4E-PYC.AX	PRICE SENSITIVE	30/08/16	89.14KB	Share
PYC	Operational Update-PYC.AX	PRICE SENSITIVE	27/07/16	1.2MB	Share
PYC	Appendix 4C - quarterly-PYC.AX	PRICE SENSITIVE	26/07/16	114.36KB	Share
PYC	Chief Executive Officer Resignation-PYC.AX	PRICE SENSITIVE	18/07/16	18.48KB	Share
PYC	Cell-Penetrating Phylomers Improve Delivery of Drugs-PYC.AX	PRICE SENSITIVE	15/06/16	44.77KB	Share
PYC	Shareholder Update-PYC.AX	PRICE SENSITIVE	23/05/16	204.74KB	Share
PYC	Appendix 4C - quarterly-PYC.AX	PRICE SENSITIVE	29/04/16	27.58KB	Share
PYC	Half Yearly Report and Accounts	PRICE SENSITIVE	01/03/16	251.59KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/16	27.95KB	Share
PYC	Combination therapy escalates potency of Phylogica peptides	PRICE SENSITIVE	09/12/15	51.58KB	Share
PYC	Proprietary anti-cancer drug candidates	PRICE SENSITIVE	16/11/15	33.06KB	Share
PYC	Animal model cancer studies	PRICE SENSITIVE	05/11/15	231.2KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	30/10/15	28.49KB	Share
PYC	Preliminary Final Report	PRICE SENSITIVE	01/09/15	97.2KB	Share
PYC	Entitlement Issue Supplementary Prospectus	PRICE SENSITIVE	04/08/15	32.59KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/15	52.43KB	Share
PYC	Australian Research Council Grant	PRICE SENSITIVE	17/07/15	82.76KB	Share
PYC	Entitlement Issue Prospectus	PRICE SENSITIVE	02/07/15	168.09KB	Share
PYC	Entitlement Issue	PRICE SENSITIVE	02/07/15	40.25KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/15	28.06KB	Share
PYC	Phylogica licenses peptides to UK company	PRICE SENSITIVE	07/04/15	79.46KB	Share
PYC	Cancer pilot study success	PRICE SENSITIVE	30/03/15	78.01KB	Share
PYC	Response to ASX Query - Price Query	PRICE SENSITIVE	02/03/15	61.35KB	Share
PYC	Half Yearly Report and Accounts	PRICE SENSITIVE	27/02/15	241.28KB	Share
PYC	Europe Patent Phenotypic Screening	PRICE SENSITIVE	24/02/15	68.35KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/15	28.83KB	Share
PYC	Licensing Agreement with Genentech / Roche	PRICE SENSITIVE	22/12/14	94.39KB	Share
PYC	European Patent Synthetic Phylomers	PRICE SENSITIVE	25/11/14	123.91KB	Share
PYC	R&D Tax Rebate	PRICE SENSITIVE	05/11/14	18.66KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/14	28.55KB	Share
PYC	Grant for Cancer Drug Research	PRICE SENSITIVE	02/09/14	24.99KB	Share
PYC	Appendix 4E and Audited Annual Financial Statements	PRICE SENSITIVE	28/08/14	328.06KB	Share
PYC	Phylogica Patents Granted	PRICE SENSITIVE	28/08/14	68.7KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	29/07/14	28.59KB	Share
PYC	Shareholder Update	PRICE SENSITIVE	16/05/14	21.41KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	29/04/14	28.59KB	Share
PYC	Shareholder Update	PRICE SENSITIVE	07/04/14	62.78KB	Share
PYC	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/14	167.81KB	Share
PYC	Response to ASX price query	PRICE SENSITIVE	07/02/14	155.11KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/14	28.52KB	Share
PYC	Response to ASX Price and Volume Query	PRICE SENSITIVE	03/01/14	167.84KB	Share
PYC	Entitlement Issue Offer Document	PRICE SENSITIVE	02/12/13	154.44KB	Share
PYC	Entitlement Issue and Note Conversion	PRICE SENSITIVE	11/11/13	31.22KB	Share
PYC	Trading Halt	PRICE SENSITIVE	07/11/13	146.45KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/13	48.89KB	Share
PYC	US Patent Synthetic Phylomer Libraries	PRICE SENSITIVE	02/10/13	118.39KB	Share
PYC	Appendix 4E and Audited Annual Financial Statements	PRICE SENSITIVE	30/08/13	498.54KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	30/07/13	53.31KB	Share
PYC	CEO and Director Changes	PRICE SENSITIVE	19/07/13	21.14KB	Share
PYC	Grant Received for Phylomer Based Biosensor Device	PRICE SENSITIVE	04/07/13	22.35KB	Share
PYC	Janssen Collaboration Expanded	PRICE SENSITIVE	01/07/13	28.66KB	Share
PYC	New Patent to Discover Sophisticated Cell Penetrating Drugs	PRICE SENSITIVE	27/06/13	26.15KB	Share
PYC	European Patent Granted	PRICE SENSITIVE	24/04/13	102.58KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	17/04/13	29.2KB	Share
PYC	Core patent granted in Australia	PRICE SENSITIVE	22/03/13	29.63KB	Share
PYC	Half Yearly Report and Accounts	PRICE SENSITIVE	20/02/13	455.41KB	Share
PYC	Collaboration to Commercialise Anti Inflammatory Phylomers	PRICE SENSITIVE	05/02/13	29.18KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/13	29.85KB	Share
PYC	Janssen Collaboration Extended	PRICE SENSITIVE	31/01/13	30.6KB	Share
PYC	Phylomer Library Upgrade	PRICE SENSITIVE	22/11/12	21.36KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	25/10/12	29.63KB	Share
PYC	Converting Note Placement	PRICE SENSITIVE	16/10/12	35.54KB	Share
PYC	R&D tax offset refund	PRICE SENSITIVE	13/09/12	21.95KB	Share
PYC	Phylomer licenced to Le metier de Beaute	PRICE SENSITIVE	12/09/12	29.86KB	Share
PYC	Preliminary Final Report	PRICE SENSITIVE	21/08/12	36.32KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	10/07/12	54.68KB	Share
PYC	Pfizer Research Project Milestone	PRICE SENSITIVE	31/05/12	30.84KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	27/04/12	55.13KB	Share
PYC	Patent Granted for Synthetic Phylomer Libraries	PRICE SENSITIVE	26/04/12	37.06KB	Share
PYC	Half Year Accounts	PRICE SENSITIVE	27/02/12	442.57KB	Share
PYC	US Patent granted	PRICE SENSITIVE	23/02/12	117.88KB	Share
PYC	NAOS Increases Shareholding to 11.5%	PRICE SENSITIVE	02/02/12	27.11KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/12	74.58KB	Share
PYC	Technology Licence to Janssen Biotech	PRICE SENSITIVE	03/01/12	24.47KB	Share
PYC	Share Placement raises $2.15 Million	PRICE SENSITIVE	14/12/11	120.02KB	Share
PYC	Pfizer First Stage of Collaboration Complete	PRICE SENSITIVE	12/12/11	27.95KB	Share
PYC	Trading Halt	PRICE SENSITIVE	12/12/11	22.07KB	Share
PYC	MedImmune Antibiotic Discovery Partnership	PRICE SENSITIVE	21/11/11	28.52KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	01/11/11	69.47KB	Share
PYC	Preliminary Final Report	PRICE SENSITIVE	31/08/11	36.4KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	29/07/11	70.36KB	Share
PYC	Progress on Cell Penetrating Peptides	PRICE SENSITIVE	25/05/11	4.87MB	Share
PYC	Roche Collaboration Extended	PRICE SENSITIVE	23/05/11	33.69KB	Share
PYC	Collaboration with PEPSCAN	PRICE SENSITIVE	10/05/11	94.47KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	29/04/11	40.82KB	Share
PYC	New US Screening Patent Granted	PRICE SENSITIVE	11/04/11	45.07KB	Share
PYC	Phylogica Limited Share Placement raises $5.2 million	PRICE SENSITIVE	25/03/11	84.87KB	Share

PYC Response to ASX Query
24/07/17	PRICE SENSITIVE	161.27KB	Share
PYC Operational Update June quarter
11/07/17	PRICE SENSITIVE	208.37KB	Share
PYC CEO and CSO Appointments
19/06/17	PRICE SENSITIVE	90.08KB	Share
PYC Appendix 4C - quarterly
26/04/17	PRICE SENSITIVE	50.08KB	Share
PYC Operational Update March Quarter
04/04/17	PRICE SENSITIVE	237.51KB	Share
PYC Half Yearly Report and Accounts
28/02/17	PRICE SENSITIVE	312.79KB	Share
PYC Appendix 4C - quarterly
30/01/17	PRICE SENSITIVE	157.53KB	Share
PYC Response to ASX Price Query
30/01/17	PRICE SENSITIVE	231.58KB	Share
PYC Genentech extends research collaboration period
19/12/16	PRICE SENSITIVE	139.08KB	Share
PYC NHMRC Grant Awarded to Collaborators
05/12/16	PRICE SENSITIVE	137.54KB	Share
PYC AGM Presentation to Shareholders
25/11/16	PRICE SENSITIVE	3.38MB	Share
PYC Appendix 4C - quarterly-PYC.AX
31/10/16	PRICE SENSITIVE	157.1KB	Share
PYC Shareholder Update-PYC.AX
30/09/16	PRICE SENSITIVE	697.77KB	Share
PYC Appendix 4E-PYC.AX
30/08/16	PRICE SENSITIVE	89.14KB	Share
PYC Operational Update-PYC.AX
27/07/16	PRICE SENSITIVE	1.2MB	Share
PYC Appendix 4C - quarterly-PYC.AX
26/07/16	PRICE SENSITIVE	114.36KB	Share
PYC Chief Executive Officer Resignation-PYC.AX
18/07/16	PRICE SENSITIVE	18.48KB	Share
PYC Cell-Penetrating Phylomers Improve Delivery of Drugs-PYC.AX
15/06/16	PRICE SENSITIVE	44.77KB	Share
PYC Shareholder Update-PYC.AX
23/05/16	PRICE SENSITIVE	204.74KB	Share
PYC Appendix 4C - quarterly-PYC.AX
29/04/16	PRICE SENSITIVE	27.58KB	Share
PYC Half Yearly Report and Accounts
01/03/16	PRICE SENSITIVE	251.59KB	Share
PYC Appendix 4C - quarterly
29/01/16	PRICE SENSITIVE	27.95KB	Share
PYC Combination therapy escalates potency of Phylogica peptides
09/12/15	PRICE SENSITIVE	51.58KB	Share
PYC Proprietary anti-cancer drug candidates
16/11/15	PRICE SENSITIVE	33.06KB	Share
PYC Animal model cancer studies
05/11/15	PRICE SENSITIVE	231.2KB	Share
PYC Appendix 4C - quarterly
30/10/15	PRICE SENSITIVE	28.49KB	Share
PYC Preliminary Final Report
01/09/15	PRICE SENSITIVE	97.2KB	Share
PYC Entitlement Issue Supplementary Prospectus
04/08/15	PRICE SENSITIVE	32.59KB	Share
PYC Appendix 4C - quarterly
31/07/15	PRICE SENSITIVE	52.43KB	Share
PYC Australian Research Council Grant
17/07/15	PRICE SENSITIVE	82.76KB	Share
PYC Entitlement Issue Prospectus
02/07/15	PRICE SENSITIVE	168.09KB	Share
PYC Entitlement Issue
02/07/15	PRICE SENSITIVE	40.25KB	Share
PYC Appendix 4C - quarterly
30/04/15	PRICE SENSITIVE	28.06KB	Share
PYC Phylogica licenses peptides to UK company
07/04/15	PRICE SENSITIVE	79.46KB	Share
PYC Cancer pilot study success
30/03/15	PRICE SENSITIVE	78.01KB	Share
PYC Response to ASX Query - Price Query
02/03/15	PRICE SENSITIVE	61.35KB	Share
PYC Half Yearly Report and Accounts
27/02/15	PRICE SENSITIVE	241.28KB	Share
PYC Europe Patent Phenotypic Screening
24/02/15	PRICE SENSITIVE	68.35KB	Share
PYC Appendix 4C - quarterly
30/01/15	PRICE SENSITIVE	28.83KB	Share
PYC Licensing Agreement with Genentech / Roche
22/12/14	PRICE SENSITIVE	94.39KB	Share
PYC European Patent Synthetic Phylomers
25/11/14	PRICE SENSITIVE	123.91KB	Share
PYC R&D Tax Rebate
05/11/14	PRICE SENSITIVE	18.66KB	Share
PYC Appendix 4C - quarterly
31/10/14	PRICE SENSITIVE	28.55KB	Share
PYC Grant for Cancer Drug Research
02/09/14	PRICE SENSITIVE	24.99KB	Share
PYC Appendix 4E and Audited Annual Financial Statements
28/08/14	PRICE SENSITIVE	328.06KB	Share
PYC Phylogica Patents Granted
28/08/14	PRICE SENSITIVE	68.7KB	Share
PYC Appendix 4C - quarterly
29/07/14	PRICE SENSITIVE	28.59KB	Share
PYCShareholder Update
16/05/14	PRICE SENSITIVE	21.41KB	Share
PYCAppendix 4C - quarterly
29/04/14	PRICE SENSITIVE	28.59KB	Share
PYCShareholder Update
07/04/14	PRICE SENSITIVE	62.78KB	Share
PYCHalf Yearly Report and Accounts
28/02/14	PRICE SENSITIVE	167.81KB	Share
PYCResponse to ASX price query
07/02/14	PRICE SENSITIVE	155.11KB	Share
PYCAppendix 4C - quarterly
31/01/14	PRICE SENSITIVE	28.52KB	Share
PYCResponse to ASX Price and Volume Query
03/01/14	PRICE SENSITIVE	167.84KB	Share
PYCEntitlement Issue Offer Document
02/12/13	PRICE SENSITIVE	154.44KB	Share
PYCEntitlement Issue and Note Conversion
11/11/13	PRICE SENSITIVE	31.22KB	Share
PYCTrading Halt
07/11/13	PRICE SENSITIVE	146.45KB	Share
PYCAppendix 4C - quarterly
31/10/13	PRICE SENSITIVE	48.89KB	Share
PYCUS Patent Synthetic Phylomer Libraries
02/10/13	PRICE SENSITIVE	118.39KB	Share
PYCAppendix 4E and Audited Annual Financial Statements
30/08/13	PRICE SENSITIVE	498.54KB	Share
PYCAppendix 4C - quarterly
30/07/13	PRICE SENSITIVE	53.31KB	Share
PYCCEO and Director Changes
19/07/13	PRICE SENSITIVE	21.14KB	Share
PYCGrant Received for Phylomer Based Biosensor Device
04/07/13	PRICE SENSITIVE	22.35KB	Share
PYCJanssen Collaboration Expanded
01/07/13	PRICE SENSITIVE	28.66KB	Share
PYCNew Patent to Discover Sophisticated Cell Penetrating Drugs
27/06/13	PRICE SENSITIVE	26.15KB	Share
PYCEuropean Patent Granted
24/04/13	PRICE SENSITIVE	102.58KB	Share
PYCAppendix 4C - quarterly
17/04/13	PRICE SENSITIVE	29.2KB	Share
PYCCore patent granted in Australia
22/03/13	PRICE SENSITIVE	29.63KB	Share
PYCHalf Yearly Report and Accounts
20/02/13	PRICE SENSITIVE	455.41KB	Share
PYCCollaboration to Commercialise Anti Inflammatory Phylomers
05/02/13	PRICE SENSITIVE	29.18KB	Share
PYCAppendix 4C - quarterly
31/01/13	PRICE SENSITIVE	29.85KB	Share
PYCJanssen Collaboration Extended
31/01/13	PRICE SENSITIVE	30.6KB	Share
PYCPhylomer Library Upgrade
22/11/12	PRICE SENSITIVE	21.36KB	Share
PYCAppendix 4C - quarterly
25/10/12	PRICE SENSITIVE	29.63KB	Share
PYCConverting Note Placement
16/10/12	PRICE SENSITIVE	35.54KB	Share
PYCR&D tax offset refund
13/09/12	PRICE SENSITIVE	21.95KB	Share
PYCPhylomer licenced to Le metier de Beaute
12/09/12	PRICE SENSITIVE	29.86KB	Share
PYCPreliminary Final Report
21/08/12	PRICE SENSITIVE	36.32KB	Share
PYCAppendix 4C - quarterly
10/07/12	PRICE SENSITIVE	54.68KB	Share
PYCPfizer Research Project Milestone
31/05/12	PRICE SENSITIVE	30.84KB	Share
PYCAppendix 4C - quarterly
27/04/12	PRICE SENSITIVE	55.13KB	Share
PYCPatent Granted for Synthetic Phylomer Libraries
26/04/12	PRICE SENSITIVE	37.06KB	Share
PYCHalf Year Accounts
27/02/12	PRICE SENSITIVE	442.57KB	Share
PYCUS Patent granted
23/02/12	PRICE SENSITIVE	117.88KB	Share
PYCNAOS Increases Shareholding to 11.5%
02/02/12	PRICE SENSITIVE	27.11KB	Share
PYCAppendix 4C - quarterly
31/01/12	PRICE SENSITIVE	74.58KB	Share
PYCTechnology Licence to Janssen Biotech
03/01/12	PRICE SENSITIVE	24.47KB	Share
PYCShare Placement raises $2.15 Million
14/12/11	PRICE SENSITIVE	120.02KB	Share
PYCPfizer First Stage of Collaboration Complete
12/12/11	PRICE SENSITIVE	27.95KB	Share
PYCTrading Halt
12/12/11	PRICE SENSITIVE	22.07KB	Share
PYCMedImmune Antibiotic Discovery Partnership
21/11/11	PRICE SENSITIVE	28.52KB	Share
PYCAppendix 4C - quarterly
01/11/11	PRICE SENSITIVE	69.47KB	Share
PYCPreliminary Final Report
31/08/11	PRICE SENSITIVE	36.4KB	Share
PYCAppendix 4C - quarterly
29/07/11	PRICE SENSITIVE	70.36KB	Share
PYCProgress on Cell Penetrating Peptides
25/05/11	PRICE SENSITIVE	4.87MB	Share
PYCRoche Collaboration Extended
23/05/11	PRICE SENSITIVE	33.69KB	Share
PYCCollaboration with PEPSCAN
10/05/11	PRICE SENSITIVE	94.47KB	Share
PYCAppendix 4C - quarterly
29/04/11	PRICE SENSITIVE	40.82KB	Share
PYCNew US Screening Patent Granted
11/04/11	PRICE SENSITIVE	45.07KB	Share
PYCPhylogica Limited Share Placement raises $5.2 million
25/03/11	PRICE SENSITIVE	84.87KB	Share

REFRESH

First 2 3

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.33		Change 0.080(6.43%)		Mkt cap ! $772.8M

Open	High	Low	Value	Volume
$1.27	$1.35	$1.21	$763.8K	595.4K

Buyers (Bids)

No.	Vol.	Price($)
2	97719	$1.30

Sellers (Offers)

Price($)	Vol.	No.
$1.33	6599	1

View Market Depth

No.	Vol.	Price($)
2	97719	1.300
1	4027	1.240
1	40000	1.220
1	1000	1.200
2	10830	1.190

Price($)	Vol.	No.
1.325	6599	1
1.395	7168	1
1.400	18450	1
1.420	26097	2
1.430	13000	1

Last trade - 16.10pm 08/08/2025 (20 minute delay)

PYC (ASX) Chart

PYC THERAPEUTICS LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories